On 1 October 2018 Company commenced a review of strategic options supporting further development of the capital group. [/vc_column_text][vc_column_text]The review of strategic options will enable identification of possible development directions of the Group’s operations, resulting in the selection of the preferred measures to achieve the Group’s long-term goal, which is to ensure the best possible position for the Group on the market for advanced systems for cardiology and to maximize value for the Company’s shareholders.
The Management Board of the Company will carry out an analysis of different strategic options in all areas of the Group’s business operations; it will also consider obtaining a strategic or financial investor, entering into a strategic alliance, performing an otherwise-structured transaction as well as none of the listed measures.
The communication consultant of the Company in the area of the strategic options review is CC Group Sp. z o.o.